Healthcare Services

Autism Spectrum Disorder Diagnostics Market Future Analysis Covering Industry Shifts And Growth Potential

May 27, 2026June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Expected Market Size Of The Autism Spectrum Disorder Diagnostics Market In 2026 And How Much Will It Reach By 2030?

The autism spectrum disorder diagnostics market has demonstrated significant growth in recent years. It is projected to increase from $28.87 billion in 2025 to $30.37 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.2%. This past expansion can be attributed to factors such as enhanced awareness of autism spectrum disorders, the broadening of pediatric developmental screening programs, the availability of qualified diagnostic professionals, the increasing application of behavioral assessment frameworks, and better access to diagnostic services.

The autism spectrum disorder diagnostics market size is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $36.76 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the forecast period include an escalating demand for early intervention services, the growing adoption of AI-assisted diagnostic tools, the broadening of tele-diagnostics platforms, increased investment in neurodevelopmental research, and enhanced standardization of diagnostic criteria. Key trends anticipated for the forecast period comprise a greater uptake of digital screening instruments, wider utilization of standardized behavioral assessment scales, an increase in early childhood diagnostic programs, the growing incorporation of multidisciplinary diagnostic approaches, and a heightened emphasis on timely and precise detection.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16593&type=smp

What Key Growth Drivers Are Influencing The Autism Spectrum Disorder Diagnostics Market?

The expansion of specialized diagnostic centers is anticipated to fuel the future development of the autism spectrum disorders diagnostic market. An autism-focused diagnostic center refers to a facility comprising healthcare professionals, psychologists, and specialists who carry out thorough evaluations and assessments for diagnosing autism spectrum disorder. This increase in specialized diagnostic centers stems from advancements in diagnosis, a need for extensive care, professional development, ongoing research, and the recognition of autism as a significant public health concern. These centers are crucial for boosting diagnostic precision, promoting early intervention, and improving results for individuals with ASD, achieved through their provision of specialized knowledge, sophisticated diagnostic instruments, extensive evaluations, customized treatment strategies, family assistance, and avenues for research partnerships. For example, in July 2025, NHS England, the U.K.-based government agency responsible for health services, reported that its national Community Diagnostic Centre (CDC) Programme had sanctioned 170 CDC sites throughout England. By August 2024, 165 of these sites were functioning in diverse environments; 135 of them were operating from their permanent CDC building, with the remainder utilizing temporary facilities until their permanent CDC buildings are finalized. Consequently, the expansion of specialized diagnostic centers is propelling the growth within the autism spectrum disorders diagnostic market.

How Is Segment Classification Applied In The Autism Spectrum Disorder Diagnostics Market?

The autism spectrum disorder diagnostics market covered in this report is segmented –

1) By Diagnostic Method: Behavioral And Developmental Screening Tools, Standardized Diagnostic Assessments, Genetic And Molecular Testing, Digital And AI-Based Diagnostic Tools

2) By Test Type: Observational And Questionnaire-Based Tests, Cognitive And Neurodevelopmental Assessments, Biomarker And Genetic Tests, Eye-Tracking And Sensor-Based Tests

3) By Age Group: Infants And Toddlers (0–3 years), Children (4–12 years), Adolescents And Adults

4) By End User: Hospitals And Specialty Clinics, Diagnostic And Reference Laboratories, Academic And Research Institutes

Subsegments:

1) By Behavioral And Developmental Screening Tools: Parent-Reported Screening Questionnaires, Clinician-Administered Developmental Checklists

2) By Standardized Diagnostic Assessments: Structured Behavioral Observation Assessments, Standardized Diagnostic Interviews

3) By Genetic And Molecular Testing: Chromosomal Microarray Analysis (CMA), Next-Generation Sequencing (NGS) Panels

4) By Digital And AI-Based Diagnostic Tools: AI-Driven Behavioral Analysis Platforms, Digital Biomarker & Eye-Tracking Systems

What Trends Are Influencing The Autism Spectrum Disorder Diagnostics Market?

Leading firms operating in the autism spectrum disorder diagnostics market are developing advanced solutions, such as devices that utilize Dynamic Quantification of Social-Visual Engagement (DQSVE), to gain a competitive edge. This technology captures and analyzes a child’s continuous gaze behavior at a rate of 120 times per second. For instance, in September 2023, Marcus Autism Center, a US-based nonprofit healthcare and research organization, launched the EarliPoint™ Evaluation, a pioneering FDA-authorized device designed for the early diagnosis of autism spectrum disorder (ASD) in children aged 16 to 30 months. This innovative tool leverages eye-tracking technology to assess children’s social interactions, significantly reducing the time required for diagnosis from hours to approximately 12 minutes.

Which Companies Are Influencing The Autism Spectrum Disorder Diagnostics Market?

Major companies operating in the autism spectrum disorder diagnostics market are Quest Diagnostics, Laboratory Corporation of America LabCorp, ARUP Laboratories, Invitae, Natera, Fulgent Genetics, Myriad Genetics, Sema4, PreventionGenetics, Color Genomics, Cognoa, EarliTec Diagnostics, Eurofins Scientific, Sonic Healthcare, Cerba HealthCare, Baylor Genetics, Mayo Clinic Laboratories, Bionano Genomics, Genomind, Blueprint Genetics

Access The Complete Autism Spectrum Disorder Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/autism-spectrum-disorder-diagnostics-global-market-report

Which Region Contributes The Most To The Autism Spectrum Disorder Diagnostics Market?

Asia-Pacific was the largest region in the autism spectrum disorder diagnostics market in 2025. The regions covered in the autism spectrum disorder diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Autism Spectrum Disorder Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16593&type=smp

Browse Through More Reports Similar to the Global Autism Spectrum Disorder Diagnostics Market 2026, By The Business Research Company

Autism Spectrum Disorders Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/autism-spectrum-disorders-treatment-global-market-report

Clinical Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Rare Disease Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795